Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: News
No Comments
Once a niche method in academic labs, synthetic biology is now an essential tool for a broad range of applications. In the drug discovery pipeline, there…
By Pharmatrax Author
Category: Technoloy
No Comments
By combining machine learning and quantum physics, researchers could speed the process of drug discovery for COVID-19. Researchers from Penn State College of Engineering are aiming to…
By Pharmatrax Author
Category: Technoloy
No Comments
Scientists have developed a technique that could significantly reduce the time to discover potential new antibody-based drugs to treat disease. Antibodies are produced by the…
By Pharmatrax Author
Category: Technoloy
No Comments
Scientists have developed a technique that could significantly reduce the time of discovering potential new antibody-based drugs to treat disease. Antibodies are produced by the…
By pharmatrax
Category: Technoloy
No Comments
In a world-first, a medicine developed by artificial intelligence may be used to treat patients with obsessive-compulsive disorder. The news is remarkable and hints that…
By pharmatrax
Category: News
No Comments
You’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its…
By pharmatrax
Category: News
No Comments
A study has suggested that while funding for artificial intelligence in pharma was $5.2bn in 2019, overall investment is slowing. New research has revealed that…
By pharmatrax
Category: News
No Comments
China has become the world’s second-largest pharmaceutical market after the US, taking a 30% share of global business China’s pharmaceutical market has been constantly growing…
By pharmatrax
Category: Technoloy
No Comments
Pharmaceutical drugs are a valuable part of patient care throughout the world. For doctors to adequately care for their patients, drug safety must be monitored…
By pharmatrax
Category: Technoloy
No Comments
Last year, the FDA approved 59 new molecular entities for the US market, the highest number ever approved in a single year. A key driver of this…